Literature DB >> 26548949

PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.

Cheng Zhang1, Wei Tian1, Lin Meng1, Like Qu1, Chengchao Shou2.   

Abstract

UNLABELLED: Phosphatase of regenerating liver-3 (PRL-3) has been implicated in controlling cancer cell invasiveness. Deregulated expression of PRL-3 is involved in cancer progression and predicts poor overall survival. Recent studies have revealed critical roles for microRNAs in various cellular processes, including tumorigenic development. In this study, we aimed to explore the linkage between PRL-3 and microRNAs in gastric cancer. We found that PRL-3 transcript levels were positively correlated with miR-210 levels in gastric cancer tissues. In gastric cancer cells, PRL-3 upregulated miR-210 expression in a HIF-1α-dependent fashion under normoxia and hypoxia. In addition, PRL-3 activated NF-κB signaling and promoted HIF-1α expression through modulating phosphorylation of p65. NF-κB signaling, HIF-1α, and miR-210 partially contributed to PRL-3-induced migration and invasion. Furthermore, the levels of PRL-3, HIF-1α, and miR-210 transcripts inversely affected the overall survival of gastric cancer patients. Our work identified the existence of a PRL-3-NF-κB-HIF-1α-miR-210 axis, thus providing new insight into the role of PRL-3 in promoting gastric cancer invasiveness. KEY MESSAGE: PRL-3 regulates microRNA in gastric cancer. PRL-3 elevates hsa-miR-210 by upregulating HIF-1α. PRL-3 activates a NF-κB-HIF-1α-miR-210 axis by enhancing the phosphorylation of p65. PRL-3 promotes cell migration and invasion via the NF-κB-HIF-1α-miR-210 axis. High levels of PRL-3 and miR-210 are related with poor OS in gastric cancer.

Entities:  

Keywords:  Gastric cancer invasiveness; HIF-1α; Hypoxia; NF-κB signaling; PRL-3; miR-210

Mesh:

Substances:

Year:  2015        PMID: 26548949     DOI: 10.1007/s00109-015-1350-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  50 in total

Review 1.  Hypoxia-inducible factors in physiology and medicine.

Authors:  Gregg L Semenza
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

2.  PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.

Authors:  Haihe Wang; Samantha Yiling Quah; Jing Ming Dong; Edward Manser; Jing Ping Tang; Qi Zeng
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

3.  Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis.

Authors:  M R Bordoli; D P Stiehl; L Borsig; G Kristiansen; S Hausladen; P Schraml; R H Wenger; G Camenisch
Journal:  Oncogene       Date:  2010-09-20       Impact factor: 9.867

4.  High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.

Authors:  U A Miskad; S Semba; H Kato; Y Matsukawa; Y Kodama; E Mizuuchi; N Maeda; K Yanagihara; H Yokozaki
Journal:  Virchows Arch       Date:  2007-01-18       Impact factor: 4.064

5.  Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression.

Authors:  Nicoletta Bianchi; Cristina Zuccato; Ilaria Lampronti; Monica Borgatti; Roberto Gambari
Journal:  BMB Rep       Date:  2009-08-31       Impact factor: 4.778

6.  2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.

Authors:  Li Ma; Guangxin Li; Huaqiang Zhu; Xuesong Dong; Dali Zhao; Xian Jiang; Jie Li; Haiquan Qiao; Shaobin Ni; Xueying Sun
Journal:  Cancer Lett       Date:  2014-09-11       Impact factor: 8.679

7.  miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer.

Authors:  J Zhang; Z Xiao; D Lai; J Sun; C He; Z Chu; H Ye; S Chen; J Wang
Journal:  Br J Cancer       Date:  2012-06-07       Impact factor: 7.640

8.  Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity.

Authors:  Sarah R Walmsley; Cristin Print; Neda Farahi; Carole Peyssonnaux; Randall S Johnson; Thorsten Cramer; Anastasia Sobolewski; Alison M Condliffe; Andrew S Cowburn; Nicola Johnson; Edwin R Chilvers
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

9.  miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer.

Authors:  Antonis Giannakakis; Raphael Sandaltzopoulos; Joel Greshock; Shun Liang; Jia Huang; Kosei Hasegawa; Chunsheng Li; Ann O'Brien-Jenkins; Dionyssios Katsaros; Barbara L Weber; Celeste Simon; George Coukos; Lin Zhang
Journal:  Cancer Biol Ther       Date:  2007-11-14       Impact factor: 4.742

10.  ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis.

Authors:  Cinzia Martinengo; Teresa Poggio; Matteo Menotti; Maria Stella Scalzo; Cristina Mastini; Chiara Ambrogio; Elisa Pellegrino; Ludovica Riera; Roberto Piva; Domenico Ribatti; Fabio Pastorino; Patrizia Perri; Mirco Ponzoni; Qi Wang; Claudia Voena; Roberto Chiarle
Journal:  Cancer Res       Date:  2014-09-05       Impact factor: 12.701

View more
  15 in total

1.  MicroRNA-674-5p induced by HIF-1α targets XBP-1 in intestinal epithelial cell injury during endotoxemia.

Authors:  Zhihao Liu; Jie Jiang; Weigang Dai; Hongyan Wei; Xiaofei Zhang; Zhen Yang; Yan Xiong
Journal:  Cell Death Discov       Date:  2020-06-04

Review 2.  Reciprocal regulations between miRNAs and HIF-1α in human cancers.

Authors:  Wanli Yang; Jiaojiao Ma; Wei Zhou; Bo Cao; Xin Zhou; Hongwei Zhang; Qingchuan Zhao; Liu Hong; Daiming Fan
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

Review 3.  Signaling pathways and therapeutic interventions in gastric cancer.

Authors:  Zi-Ning Lei; Qiu-Xu Teng; Qin Tian; Wei Chen; Yuhao Xie; Kaiming Wu; Qianlin Zeng; Leli Zeng; Yihang Pan; Zhe-Sheng Chen; Yulong He
Journal:  Signal Transduct Target Ther       Date:  2022-10-08

4.  Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion.

Authors:  Yongyong Yang; Shenyi Lian; Lin Meng; Like Qu; Chengchao Shou
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

Review 5.  NF-κB Signaling in Gastric Cancer.

Authors:  Olga Sokolova; Michael Naumann
Journal:  Toxins (Basel)       Date:  2017-03-28       Impact factor: 4.546

6.  PRL-3 promotes telomere deprotection and chromosomal instability.

Authors:  Shenyi Lian; Lin Meng; Yongyong Yang; Ting Ma; Xiaofang Xing; Qin Feng; Qian Song; Caiyun Liu; Zhihua Tian; Like Qu; Chengchao Shou
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

7.  MicroRNA-674-5p induced by HIF-1α targets XBP-1 in intestinal epithelial cell injury during endotoxemia.

Authors:  Zhihao Liu; Jie Jiang; Weigang Dai; Hongyan Wei; Xiaofei Zhang; Zhen Yang; Yan Xiong
Journal:  Cell Death Discov       Date:  2020-06-04

8.  Prognostic value of microRNAs in gastric cancer: a meta-analysis.

Authors:  Yue Zhang; Dong-Hui Guan; Rong-Xiu Bi; Jin Xie; Chuan-Hua Yang; Yue-Hua Jiang
Journal:  Oncotarget       Date:  2017-06-21

9.  PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.

Authors:  Nan Mu; Jintao Gu; Nannan Liu; Xiaochang Xue; Zhen Shu; Kuo Zhang; Tonglie Huang; Chu Chu; Wangqian Zhang; Li Gong; Huadong Zhao; Bo Jia; Dakuan Gao; Lei Shang; Wei Zhang; Qingdong Guo
Journal:  Theranostics       Date:  2018-02-07       Impact factor: 11.556

10.  The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.

Authors:  Wei Peng; Ya-Nan Liu; Si-Qiang Zhu; Wen-Qiang Li; Feng-Cheng Guo
Journal:  Cancer Med       Date:  2018-07-12       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.